CompletedPhase 1NCT00607763

Study of Mycamine® in Infants and Toddlers With Fungal Infections to Evaluate Safety and Blood Levels of the Drug

Studying Invasive candidiasis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Astellas Pharma Inc
Principal Investigator
Central Contact
Astellas Pharma Global Development
Intervention
Micafungin (Mycamine)(drug)
Enrollment
9 target
Eligibility
All sexes
Timeline
2007 – 2009

Study locations (6)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00607763 on ClinicalTrials.gov

Other trials for Invasive candidiasis

Additional recruiting or active studies for the same condition.

See all trials for Invasive candidiasis →

← Back to all trials